Xcout Intel
Harpoon Therapeutics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Harpoon Therapeutics, Inc. among drug discovery companies — ranked by similarity to what Harpoon Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see Harpoon Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Harpoon Therapeutics, Inc.
Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company headquartered in South San Francisco, California. It specializes in developing novel T-cell engaging therapies for the treatment of cancer.
Harpoon Therapeutics, Inc. at a glance
Harpoon Therapeutics, Inc. is a drug discovery company headquartered in United States. Its most recent funding round raised $100.2M in October 2023. Xcout tracks 1 named person at Harpoon Therapeutics, Inc., including Rob Davis (Chairman of the Board and Chief Executive Officer).
Harpoon Therapeutics, Inc. leadership
- Rob DavisChairman of the Board and Chief Executive Officer
Harpoon Therapeutics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $100.2M | — | |
| SEC Form D filing | $25M | — | |
| Series C | $70M | — | |
| SEC Form D filing | $25.2M | — | |
| Series B | $45M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Harpoon Therapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to Harpoon Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biopharma
Arch Oncology is a clinical-stage immuno-oncology company headquartered in Brisbane, California, with an additional scientific research laboratory in St. Louis, Missouri. The company develops antibody-based cancer therapies.
Similar drug discovery company
BobcatBio, Inc. is a clinical-stage biotechnology company founded in 2020 and headquartered in Hummelstown, Pennsylvania. The company focuses on developing macrophage-based cell therapies and cancer-specific immunotherapies, including its lead cellular therapy candidate RB-1355, for the treatment of solid tumors.
Similar drug discovery company
Nura Bio Inc. is a privately held biopharmaceutical company headquartered in South San Francisco, California, founded in 2018 to develop novel treatments for neurological diseases.
Similar drug discovery company
Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in Boston, Massachusetts. The company discovers and develops Anticalin-based drugs designed to address significant medical needs.
Similar drug discovery company
Promontory Therapeutics Inc. is a privately held, clinical-stage pharmaceutical company founded in 2010 and headquartered in New York, NY. The firm focuses on small molecule immunotherapy.
Biopharmaceuticals
Amunix Pharmaceuticals, Inc. is a biopharmaceutical company located in South San Francisco and Mountain View, California. The company focuses on oncology, leveraging its proprietary Pro-XTEN technology platform to engineer novel protein therapeutics.
Biopharmaceuticals
Carrick Therapeutics is a biopharmaceutical company with its corporate headquarters located in Boston, Massachusetts, focused on discovering and developing innovative cancer treatments.
Biopharmaceuticals
ARMO BioSciences is a late-stage immuno-oncology company that develops a pipeline of novel, proprietary product candidates designed to activate the immune system of cancer patients to recognize and eradicate tumors.
Biopharmaceuticals
Lifordi Immunotherapeutics, Inc. is a clinical-stage biotechnology company based in Burlington, Massachusetts, focused on developing antibody-drug conjugates (ADCs).
BioPharmaceuticals
Artielle Immunotherapeutics is a venture-backed, clinical-stage biotechnology company pioneering novel therapeutics. It maintains its headquarters in Portland, Oregon, with additional presence in San Mateo, California.
Biopharmaceuticals
Estrella Immunopharma, Inc. is an early-stage biopharmaceutical enterprise focused on creating T-cell therapies for various blood cancers and solid tumors, with its primary activities centered in the United States. The company's lead investigational drugs include EB103, which is in preclinical development for diffuse large B-cell lymphoma, and EB104, intended for the treatment of both diffuse large B-cell lymphoma and acute lymphocytic leukemia. Estrella also maintains a collaborative agreement with Imugene Limited, working together to develop solid tumor therapies that integrate Imugene's CF33-CD19t product candidate with Estrella's EB103. The company is based in Emeryville, California.
Biopharmaceuticals
Achaogen Inc was a biopharmaceutical company headquartered in South San Francisco, California. The company focused on discovering, developing, and commercializing novel antibacterial treatments.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Harpoon Therapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Harpoon Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →